Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TECPR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MIR4707 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RARRES3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCED1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKR7A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD51D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM140 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on